Qlucore
Qlucore is a precision medicine software company founded in 2007, originating from Lund University, Sweden. It develops intuitive, visualization-based bioinformatics software for research and clinical diagnostics, including multi-omics data analysis and AI-powered disease-specific machine learning classifiers. Key products include Qlucore Omics Explorer for research data visualization and analysis, Qlucore Insights for disease subtyping, and Qlucore Diagnostics, the first CE-marked IVDR-certified diagnostic test for pediatric leukemia. The company serves researchers, clinicians, and pharmaceutical companies globally, enabling faster, simpler, and more accurate analysis of complex genetic and proteomic data to advance precision oncology and companion diagnostics.
Qlucore
Qlucore is a precision medicine software company founded in 2007, originating from Lund University, Sweden. It develops intuitive, visualization-based bioinformatics software for research and clinical diagnostics, including multi-omics data analysis and AI-powered disease-specific machine learning classifiers. Key products include Qlucore Omics Explorer for research data visualization and analysis, Qlucore Insights for disease subtyping, and Qlucore Diagnostics, the first CE-marked IVDR-certified diagnostic test for pediatric leukemia. The company serves researchers, clinicians, and pharmaceutical companies globally, enabling faster, simpler, and more accurate analysis of complex genetic and proteomic data to advance precision oncology and companion diagnostics.
TL;DR
Founded: 2007 (originated from Lund University)
Core product areas: Visualization-driven bioinformatics, multi-omics analysis, diagnostic classifiers
Regulated diagnostic: CE/IVDR-certified RNA-seq diagnostic for pediatric BCP-ALL (Qlucore Diagnostics)
Offices: Lund, Sweden and New York, USA
Company Overview
Problem Domain
Bioinformatics for multi-omics data analysis and precision/companion diagnostics
Founded
2007
Industry
Biotechnology
Tech Stack
Funding Track Record
Approximately USD 840,000
Equity investment to support international expansion
SEK 30 million (reported)
Pre-IPO private placement; described as oversubscribed with institutional and private investors participating
4685060
Total funding amount reported
Investor Signal
“Eiffel Investment Group, GLD Invest, Rutger Arnhult, M2 Asset Management, European Union / EIC Accelerator, Vinnova”